Towards Healthcare
Metagenomic Sequencing Market Expands USD 2.53 Bn in 2025

Metagenomic Sequencing Market Size and Forecast 2025 Powered by AI, Whole-Genome Shotgun Techniques, and Clinical Diagnostics

Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand for biologics bolster market growth. North America led the global market owing to the availability of state-of-the-art research and development facilities and the presence of key players.

  • Insight Code: 5887
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The metagenomic sequencing market is projected to reach USD 7.63 billion by 2034, growing at a CAGR of 13.04% from 2025 to 2034.

North America is leading the metagenomic sequencing market due to the availability of state-of-the-art research and development facilities, technological advancements, and the presence of key players.

The metagenomic sequencing market includes 6 segments including by sequencing approach, by platform technology, by application, by end-user, by workflow component, and by region.

Some key players include Oxford Nanopore Technologies, Pacific Biosciences, and BGI Genomics.

Metagenomics relies on the principle of genomic analysis of a sample from a complex environment containing more than one microorganism.

Metagenomic sequencing offers numerous benefits, including the identification of new microorganisms, studying the evolution of known microorganisms, and understanding the function of microbial genes.

Centers for Disease Control and Prevention, Genome Canada, GOV.UK